Ausencia de la proteína de transferencia de triglicéridos microsomal en personas con abetalipoproteinemia
Video Experimental Relacionado
Updated: Jul 29, 2026
07:32
Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
J R Wetterau1, L P Aggerbeck, M E Bouma
1Department of Metabolic Diseases, Bristol-Myers Squibb, Princeton, NJ 08543-4000.
Science (New York, N.Y.)
|November 6, 1992
Resumen
La abetalipoproteinemia, un trastorno genético, es el resultado de defectos en el ensamblaje de lipoproteínas. Los investigadores encontraron que la proteína de transferencia de triglicéridos microsomal (MTP) está ausente en los individuos afectados, lo que indica su papel crucial.
Área de la Ciencia:
- Genética Humana Genética Humana.
- Biología Molecular Biología Molecular
- La bioquímica es la bioquímica.
Sus antecedentes:
- La abetalipoproteinemia es un trastorno genético raro que afecta a la producción de lipoproteínas.
- Se caracteriza por un deterioro en el ensamblaje y la secreción de lipoproteínas de muy baja densidad (VLDL) y quilomicrones.
Objetivo del estudio:
- Para investigar el papel de la proteína de transferencia de triglicéridos microsomal (MTP) en la patogénesis de la abetalipoproteinemia.
- Para determinar si la deficiencia de MTP subyace al defecto en el ensamblaje de lipoproteínas observado en esta enfermedad.
Principales métodos:
- Análisis de la actividad de MTP y el componente proteico en muestras de biopsia intestinal.
- Comparación entre pacientes con abetalipoproteinemia y individuos de control sanos.
Principales resultados:
- La actividad de la proteína de transferencia de triglicéridos microsomal (MTP) y su componente de 88 kilodaltones se detectaron en biopsias intestinales de individuos sanos.
- Estos componentes MTP estaban notablemente ausentes en las biopsias intestinales de pacientes con abetalipoproteinemia.
Conclusiones:
- Los hallazgos sugieren fuertemente que un defecto en la MTP es la causa subyacente de la abetalipoproteinemia.
- Este estudio confirma el papel esencial de la MTP en el proceso de ensamblaje y secreción de lipoproteínas.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:26Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...